Elaine Sullivan
- Role
-
Board member
Elected to the Board in 2024 (Board Observer from 2023) and regarded as an independent board member.
- Member of the Scientific Committee
Special competencies
More than 25 years of experience in the pharmaceutical and biotech industry in senior executive positions, science, investment, business development, and start-ups. Served at AstraZeneca and Eli Lilly and Company as a member of the senior global R&D management teams.
Current positions
Member of the board of Nykode Therapeutics ASA, IP Group plc, and hVIVO Ltd; member of the supervisory board of Evotec AG.